ABSTRACT Aim: Papillary thyroid carcinoma (PTC) accounts for 80% of all thyroid malignancies and is one of the most responsive thyroid malignancies to treatment. There are three different Raf kinases implicated in the molecular genetics of tumorigenesis for the development of papillary thyroid cancer: ARAF, BRAF (BRAFV600E), and CRAF. Among the BRAFV600E mutations, T1799A ( V600E amino acid translocation) is the most common and also observed in thyroid cancer. In our study, we aimed to establish the association between BRAFV600E positivity in preoperative fine needle aspiration biopsy and prognostic factors in patients with recurrence. Methods: Preoperative fine-needle aspiration biopsy slides were obtained from patients who had previously undergone surgery for PTC and had recurrence. The cancerous areas on the slides were marked and DNA was isolated from cells within the marked areas. The presence of the BRAFV600E mutation was established from the DNA using the pyrosequencing method. Other patient prognostic criteria regarding the recurrence of PTC was also recorded and their correlation with the BRAFV600E mutation was statistically analyzed. Results: In patients who underwent surgery for recurrence of papillary thyroid cancer, the BRAFV600E positivity rate was 70.8% of the study group. Furthermore, capsular invasion, soft tissue invasion, stage, recurrence time, and lymph node metastasis positively correlated with BRAFV600E mutation. Conclusion: A positive correlation between BRAF mutation and some poor prognostic criteria in PTC was observed. Keywords: Thyroid, papillary, fine needle biopsy, poor prognosis, BRAFV600E, cytology
Cite this Article As :
Alkan S, Aksoy F, Kocamaz AH, Senturk M, Varman A, Findik S, Yildirim MS, Kisi O, Vatansev C. Correlation Between BRAFV600E Positivity and Recurrence and Poor Prognosis in Preoperative Fine Needle Aspiration Biopsy of Papillary Thyroid Carcinoma. Selcuk Med J 2024;40(2): 57-62
1. Ureles A.L, Freedman Z.R. Falk S.A, et al. Thyroidology Reflections on 20th century history Thyroid Disease, Endocrinology, Surgery, Nucleer Medicine and Radiotherapy, 2nd ed. New York: Lippincott – Raven Publishers. 1997:1-14.
2. Altun H, Hamaloğlu E, Diferansiye Tiroid Kanserleri: Sayek Temel Cerrahi 4. Baskı. 2013;171:1897-1912.
3. Kanyılmaz G, Erpolat ÖP, Akmansu M. Baş-Boyun Kanserlerinin Radyoterapi Planlamasında 18f-Fdg Pet/Bt Kullanımı. Mev Med Sci. 2021;1(3): 85-88.
4. Suliburk J, et al Surgical Management of Well-differentiated Thyroid Cancer. Surg Clin North America 2009; 89(5):1171-91.
5. Morris, L.G. and D. Myssiorek Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. The American Journal of Surgery 2010; 200(4):454-461..
6. Kurtulmus, N., et al BRAFV600E mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness. Endocrine, 2012;42(2):404-410.
7. Chunping Liu, Tianwen Chen and Zeming LiAssociations between BRAF and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis. World Journal of Surgical Oncology 2016;14(10):1186-016.
8. Tufano RP, Teixeira GV, Bishop J, et al. BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis. Medicine (Baltimore). 2012;91(5):274-286.
9. Li C, Lee KC, Schneider EB, Zeiger MA. BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis. J Clin Endocrinol Metab. 2012;97(12):4559-70.
10. Liu C, Chen T, Liu Z. Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis. World J Surg Oncol. 2016;14(1):241-54.
11. Zhang TT, Qi XZ, Chen JP, et al. The association between tumor's location and cervical lymph nodes metastasis in papillary thyroid cancer. Gland Surg. 2019;8(5):557-568
Research Paper
View as PDF
Keywords
Thyroid, Papillary, Fine needle biopsy, Poor prognosis, BRAFV600E, CYTOLOGY
